SEARCH RESULTS for NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

Recent Patent Assignments Patent Assignments - (Total found: 39)

Last Update Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame
06-Dec-2017

(X0) 12516062: COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS

(A1) 20100056467: COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS

(B2) 8492429: COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

44300/360

26-Oct-2017

(X0) 12741472: STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28

(A1) 20100278873: STIMULATION OF ANTI-TUMOR IMMUNITY USING DENDRITIC CELL/TUMOR CELL FUSIONS AND ANTI-CD3/CD28

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

43942/149

07-Aug-2017

(X0) 10974127: Taspase1 and methods of use

(A1) 20060068482: Taspase1 and methods of use

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

43200/755

31-Jul-2017

(X0) 09998027: Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

(A1) 20030093819: Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

43136/543

07-Jun-2017

(X0) 13157940: PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE

(A1) 20110311536: PREVENTION OF TYPE 1 DIABETES BY TREG VACCINATION WITH AN INSULIN MIMETOPE

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42616/933

24-May-2017

(X0) 14174072: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

(A1) 20140235479: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42464/434

15-May-2017

(X0) 13572538: ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS

(A1) 20130039974: ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42349/738

05-May-2017

(X0) 12761704: PD-1, A Receptor for B7-4, and Uses Therefor

(A1) 20110033884: PD-1, A Receptor for B7-4, and Uses Therefor

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42246/533

19-Apr-2017

(X0) 08623876: MONOCLONAL ANTIBODY THAT DETECTS APOPTOTIC ANTIGEN

(B1) 5935801: MONOCLONAL ANTIBODY THAT DETECTS APOPTOTIC ANTIGEN

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42044/869

19-Apr-2017

(X0) 09989758: DIFFUSE LARGE CELL LYMPHOMA DIAGNOSIS AND OUTCOME PREDICTION BY EXPRESSION ANALYSIS

(A1) 20030194701: DIFFUSE LARGE CELL LYMPHOMA DIAGNOSIS AND OUTCOME PREDICTION BY EXPRESSION ANALYSIS

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42045/88

19-Apr-2017

(X0) 10783994: Identification of the IkappaBNS protein and its products

(A1) 20050084916: Identification of the IkappaBNS protein and its products

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42045/313

19-Apr-2017

(X0) 13572538: ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS

(A1) 20130039974: ANTI-MUC1 ANTIBODIES FOR CANCER DIAGNOSTICS

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42045/404

14-Apr-2017

(X0) 11816402: MODULATION OF MUC1 ACTIVITY

(A1) 20080286264: MODULATION OF MUC1 ACTIVITY

(B2) 7931904: MODULATION OF MUC1 ACTIVITY

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42000/304

14-Apr-2017

(X0) 11031450: METHODS AND COMPOSITIONS FOR MODULATING GLUCONEOGENESIS USING PGC-1

(A1) 20050234001: METHODS AND COMPOSITIONS FOR MODULATING GLUCONEOGENESIS USING PGC-1

(B2) 7371529: METHODS AND COMPOSITIONS FOR MODULATING GLUCONEOGENESIS USING PGC-1

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42000/413

14-Apr-2017

(X0) 11261834: Identification of compounds that modify transcriptional responses to hypoxia

(A1) 20060172323: Identification of compounds that modify transcriptional responses to hypoxia

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

42000/686

12-Apr-2017

(X0) 13911456: Prognostic Marker for Endometrial Carcinoma

(A1) 20130338026: Prognostic Marker for Endometrial Carcinoma

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41966/965

12-Apr-2017

(X0) 14129108: SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF

(A1) 20150197497: SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41966/970

12-Apr-2017

(X0) 13157947: SPREAD CODE ALLOCATING METHOD, DESPREADING METHOD, TRANSMITTING DEVICE, RECEIVING DEVICE, COMMUNICATING DEVICE, WIRELESS BASE STATION DEVICE, AND MOBILE TERMINAL DEVICE

(A1) 20110249704: SPREAD CODE ALLOCATING METHOD, DESPREADING METHOD, TRANSMITTING DEVICE, RECEIVING DEVICE, COMMUNICATING DEVICE, WIRELESS BASE STATION DEVICE, AND MOBILE TERMINAL DEVICE

(B2) 8472480: SPREAD CODE ALLOCATING METHOD, DESPREADING METHOD, TRANSMITTING DEVICE, RECEIVING DEVICE, COMMUNICATING DEVICE, WIRELESS BASE STATION DEVICE, AND MOBILE TERMINAL DEVICE

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41967/76

12-Apr-2017

(X0) 12474555: EPOTHILONE DERIVATIVES FOR THE TREATMENT OF MULTIPLE MYELOMA

(A1) 20090233973: EPOTHILONE DERIVATIVES FOR THE TREATMENT OF MULTIPLE MYELOMA

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41967/485

12-Apr-2017

(X0) 10066443: Methods and compositions for modulating gluconeogenesis using PGC-1

(A1) 20030045470: Methods and compositions for modulating gluconeogenesis using PGC-1

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41967/809

13-Mar-2017

(X0) 11002820: Compounds or agents that inhibit and induce the formation of focal microvessel dilatations

(A1) 20050142066: Compounds or agents that inhibit and induce the formation of focal microvessel dilatations

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/259

13-Mar-2017

(X0) 14174072: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

(A1) 20140235479: SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/667

13-Mar-2017

(X0) 12601052: COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY

(A1) 20110030074: COMPOSITIONS AND METHODS FOR CANCER GENE DISCOVERY

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/695

13-Mar-2017

(X0) 12442222: METHODS FOR TREATING MICA-RELATED DISORDERS

(A1) 20100111973: METHODS FOR TREATING MICA-RELATED DISORDERS

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/741

13-Mar-2017

(X0) 11781148: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

(A1) 20080241125: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

(B2) 8129345: MUC1-IKB KINASE COMPLEXES AND THEIR ACTIVITIES

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/759

13-Mar-2017

(X0) 13094624: MODULATION OF MUC1 ACTIVITY

(A1) 20150266938: MODULATION OF MUC1 ACTIVITY

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/807

13-Mar-2017

(X0) 11883965: Telomerase RNA Subunit and Methods of Use Thereof

(A1) 20090047672: Telomerase RNA Subunit and Methods of Use Thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/824

13-Mar-2017

(X0) 10848094: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

(A1) 20040242614: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

(B2) 7119095: PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE THEREOF

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/916

13-Mar-2017

(X0) 10824321: METHODS FOR SYNTHESIS OF DIARYLMETHANES

(A1) 20040267011: METHODS FOR SYNTHESIS OF DIARYLMETHANES

(B2) 7256197: METHODS FOR SYNTHESIS OF DIARYLMETHANES

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/928

13-Mar-2017

(X0) 11027273: PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

(A1) 20050186650: PHARMACEUTICALS AND METHODS FOR TREATING HYPOXIA AND SCREENING METHODS THEREFOR

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/945

13-Mar-2017

(X0) 11963152: Methods and Compositions for Modulating Gluconeogenesis Using PGC-1

(A1) 20080248475: Methods and Compositions for Modulating Gluconeogenesis Using PGC-1

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41535/958

13-Mar-2017

(X0) 09658734: METHODS FOR IDENTIFYING COMPOUNDS WHICH MODULATE THE ACTIVITY OF MSH5

(B1) 7211375: METHODS FOR IDENTIFYING COMPOUNDS WHICH MODULATE THE ACTIVITY OF MSH5

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41536/45

13-Mar-2017

(X0) 09615387: CLONING AND CHARACTERIZATION OF A CDC 15-LIKE ADAPTOR PROTEIN (CD2BP1)

(B1) 6689868: CLONING AND CHARACTERIZATION OF A CDC 15-LIKE ADAPTOR PROTEIN (CD2BP1)

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41536/79

13-Mar-2017

(X0) 11126817: Intrabody-mediated control of immune reactions

(A1) 20060034834: Intrabody-mediated control of immune reactions

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

41536/89

06-Jan-2017

(X0) 12572538: MULTIPLEXING APPARATUS AND DEMULTIPLEXING APPARATUS

(A1) 20100021139: MULTIPLEXING APPARATUS AND DEMULTIPLEXING APPARATUS

(B2) 7856062: MULTIPLEXING APPARATUS AND DEMULTIPLEXING APPARATUS

DANA-FARBER CANCER INSTITUTE

N/A

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

40866/272

02-Dec-2016

(X0) 09967956: Stimulation of cell-mediated immune responses by targeted particulate genetic immunization

(A1) 20020054864: Stimulation of cell-mediated immune responses by targeted particulate genetic immunization

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

40486/419

19-Oct-2016

(X0) 13054468: Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof

(A1) 20110265197: Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

40038/948

19-Sep-2016

(X0) 14130145: METHODS OF PREDICTING PROGNOSIS IN CANCER

(A1) 20140302042: METHODS OF PREDICTING PROGNOSIS IN CANCER

DANA-FARBER CANCER INSTITUTE

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

39766/538

04-Mar-2016

(X0) 11176315: Noscapine derivatives as adjuvant compositions and methods of use thereof

(A1) 20060018926: Noscapine derivatives as adjuvant compositions and methods of use thereof

EMORY UNIVERSITY

NATIONAL INSTITUTES OF HEALTH- DIRECTOR DEITR

37884/681